By focusing on steady changes, Texans find the results more sustainable compared to crash diets
Your clinician and pharmacy materials explain injection sites, rotation, and storage
The injectable version is advancing to phase 3 trials in 2025
Published 2022 Sep 4
However, in a large study involving people with diabetes who had no comorbidities, GLP-1 RAs were not shown to increase the risk of developing pancreatitis at any time point up through 5 years of use.[ref][ref][ref][ref] The Cleveland Clinic now counsels that GLP-1 RA patients should be screened for pancreatitis risk factors, and a lower dose should be used to reduce the risk of pancreatitis.[ref] Related article : Pancreatitis and Genetic Risk Factors Gastroparesis: Case reports tie semaglutide to a risk of gastroparesis (very slow stomach emptying)
For weight management : For injection dosage form (Wegovy solution): Adults Initially, 0.25 milligrams injected underneath the skin in the thigh, abdomen, or upper arm as directed by your physician, once a week for 4 weeks